Related Experiment Video
Updated: May 8, 2026
05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Evaluating the Need for Anti-Inflammatory Medication Post-Laser Peripheral Iridotomy
Ari Leshno1, Eran Levanon1, Reut Singer1
1The Sam Rothberg Glaucoma Center, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel; Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Ophthalmology. Glaucoma
|May 7, 2026
Summary
Topical steroids do not appear to offer benefits following laser peripheral iridotomy (LPI) for narrow angles. This study found no significant differences in inflammation, intraocular pressure, or symptoms between steroid and placebo groups after LPI.
Area of Science:
- Ophthalmology
- Laser Surgery
- Pharmacology
Background:
- Laser peripheral iridotomy (LPI) is a common procedure for anatomical narrow angles.
- The use of adjunctive topical steroids after LPI is debated.
- Evaluating the efficacy of post-LPI topical steroids is crucial for optimizing patient care.
Purpose of the Study:
- To determine if topical steroid administration improves outcomes after elective laser peripheral iridotomy (LPI).
Main Methods:
- A prospective, randomized, double-masked, placebo-controlled trial was conducted.
- Twenty-eight patients with narrow angles underwent bilateral LPI.
- Eyes were randomized to receive either topical prednisolone acetate 1% or placebo drops post-LPI.
Main Results:
- No significant differences in anterior chamber inflammation were observed between steroid and placebo groups at 1 week or 1 month.
- Iridotomy patency rates were similar between the two treatment arms at 1 month.
- Intraocular pressure (IOP) and Ocular Surface Disease Index (OSDI) scores showed no significant differences between groups.
Conclusions:
- Topical steroids do not demonstrate a clear advantage in reducing inflammation or improving outcomes after laser peripheral iridotomy.
- Larger, multicenter studies are recommended to confirm these findings regarding post-LPI steroid use.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...